nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2008-12-1-7-13nefr-995Research ArticleПЕРЕДОВАЯ СТАТЬЯLEADING ARTICLEКОНЦЕПЦИЯ ФАКТОРОВ РИСКА В НЕФРОЛОГИИ: ВОПРОСЫ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕКCONCEPTION OF RISK FACTORS IN NEPHROLOGY: QUESTIONS OF PROPHYLAXIS AND TREATMENT OF CHRONIC KIDNEY DISEASEСмирновА. В.SmirnovA. V.
кафедра пропедевтики внутренних болезней
КаюковИ. Г.KayukovI. G.
кафедра пропедевтики внутренних болезней
ДобронравовВ. А.DobronravovV. A.
кафедра пропедевтики внутренних болезней
Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад. И.П. ПавловаRussian Federation200810012008121713Copyright © Смирнов А.В., Каюков И.Г., Добронравов В.А., 20082008Смирнов А.В., Каюков И.Г., Добронравов В.А.Smirnov A.V., Kayukov I.G., Dobronravov V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/995
.
.
хроническая болезнь почекфакторы рискапрофилактикалечениеchronic kidney diseaserisk factorsprophylaxistreatmentReferencesСмирнов АВ, Каюков ИГ, Есаян АМ и др. Превентивный подход в современной нефрологии. Нефрология 2004; 8(3): 7-14Смирнов АВ, Каюков ИГ, Есаян АМ и др. Превентивный подход в современной нефрологии. Нефрология 2004; 8(3): 7-14Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6(4): 11-17Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6(4): 11-17Есаян АМ. Тканевая ренин-ангиотензиновая система почки. Новая стратегия нефропротекции. Нефрология 2002; 6(3): 8-16Есаян АМ. Тканевая ренин-ангиотензиновая система почки. Новая стратегия нефропротекции. Нефрология 2002; 6(3): 8-16Каюков ИГ, Есаян АМ, Кучер АГ, Ермаков ЮА. Роль функционально-гемодинамическтх механизмов в прогрессировании хронического гломерулонефрита. Нефрология 1998; 2(1): 7-13Каюков ИГ, Есаян АМ, Кучер АГ, Ермаков ЮА. Роль функционально-гемодинамическтх механизмов в прогрессировании хронического гломерулонефрита. Нефрология 1998; 2(1): 7-13Смирнов АВ. Дислипопротеидемии и проблемы нефропротекции. Нефрология 2002; 6(2): 8-14Смирнов АВ. Дислипопротеидемии и проблемы нефропротекции. Нефрология 2002; 6(2): 8-14Рентц Дун Б, Андерсон Ш, Бреннер Б. Гемодинамические основы прогрессирования почечных болезней. Современная нефрология. II международный нефрологический семинар. М., 1997; 162-172Рентц Дун Б, Андерсон Ш, Бреннер Б. Гемодинамические основы прогрессирования почечных болезней. Современная нефрология. II международный нефрологический семинар. М., 1997; 162-172Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17(11): 2974-2984Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 2006; 17(11): 2974-2984Metcalfe W. How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on early chronic kidney disease. Nephrol Dial Transplant 2007; 22 [Suppl 9]:ix26-30Metcalfe W. How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on early chronic kidney disease. Nephrol Dial Transplant 2007; 22 [Suppl 9]:ix26-30Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol 2006; 17(11): 2964-2966Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol 2006; 17(11): 2964-2966Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005; 12(4): 353-365Eddy AA. Progression in chronic kidney disease. Adv Chronic Kidney Dis 2005; 12(4): 353-365Yu HT. Progression of chronic renal failure. Arch Intern Med 2003; 163(12): 1417-1429Yu HT. Progression of chronic renal failure. Arch Intern Med 2003; 163(12): 1417-1429National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266National Kidney Foundation KD: Clinical practice guidelines for chronic Kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266Мухин НА, Моисеев ВС. Пропедевтика внутренних болезней. М., 2002Мухин НА, Моисеев ВС. Пропедевтика внутренних болезней. М., 2002Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67(6) :2089-20100Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67(6) :2089-20100Смирнов АВ, Добронравов В.А, Каюков ИГ. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005; 9(3): 7-15Смирнов АВ, Добронравов В.А, Каюков ИГ. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005; 9(3): 7-15Meisinger C, Dцring A, Lцwel H. KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006; 27(10): 1245-1250Meisinger C, Dцring A, Lцwel H. KORA Study Group. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006; 27(10): 1245-1250Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20(6): 1048-1056Vanholder R, Massy Z, Argiles A et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20(6): 1048-1056Rahman M, Pressel S, Davis BR et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006; 144(3): 172-180Rahman M, Pressel S, Davis BR et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006; 144(3): 172-180A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council. Circulation 2006; 114: 1083-1087A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council. Circulation 2006; 114: 1083-1087Смирнов АВ, Добронравов ВА, Каюков ИГ, Есаян АМ. Хроническая болезнь почек: дальнейшее развитие концепции и классификации. Нефрология 2007; 11(4): 7-17Смирнов АВ, Добронравов ВА, Каюков ИГ, Есаян АМ. Хроническая болезнь почек: дальнейшее развитие концепции и классификации. Нефрология 2007; 11(4): 7-17Schmieder RE, Schrader J, Zidek W et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007; 96(5): 247-257Schmieder RE, Schrader J, Zidek W et al. Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 2007; 96(5): 247-257Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005; 46(1): 33-37Klausen KP, Scharling H, Jensen G, Jensen JS. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005; 46(1): 33-37Brantsma AH, Bakker SJ, Hillege HL et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005t; 28(10): 2525-2530Brantsma AH, Bakker SJ, Hillege HL et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005t; 28(10): 2525-2530Forman JP, Brenner BM. «Hypertension» and «microalbuminuria»: The bell tolls for thee. Kidney Int 2006; 69: 22-28Forman JP, Brenner BM. «Hypertension» and «microalbuminuria»: The bell tolls for thee. Kidney Int 2006; 69: 22-28Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908–1919Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908–1919Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2–15Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int 1997; 51: 2–15Rossing P, Hommel E, Smidt U, Parving H. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 1994; 37: 511–516Rossing P, Hommel E, Smidt U, Parving H. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 1994; 37: 511–516Locatelli F, Del Vecchio L, D’Amico M, Andrulli S. Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies? J Am Soc Nephrol 2002; 13[Suppl 3]: S196–S201Locatelli F, Del Vecchio L, D’Amico M, Andrulli S. Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies? J Am Soc Nephrol 2002; 13[Suppl 3]: S196–S201Mann JF, Gerstein HC, Yi QL et al. HOPE Investigators: Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: Results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis 2003; 42: 936–942Mann JF, Gerstein HC, Yi QL et al. HOPE Investigators: Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: Results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study. Am J Kidney Dis 2003; 42: 936–942Verhave JC, Hillege HL, Burgerhof JG et al. PREVEND Study Group: The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67: 1967–1973Verhave JC, Hillege HL, Burgerhof JG et al. PREVEND Study Group: The association between atherosclerotic risk factors and renal function in the general population. Kidney Int 2005; 67: 1967–1973MacKinnon M, Shurraw S, Akbari A et al. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 2006; 48(1): 8-20MacKinnon M, Shurraw S, Akbari A et al. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis 2006; 48(1): 8-20Bakris GL, Weir MR, Secic M et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 2004; 65(6): 1991-2002Bakris GL, Weir MR, Secic M et al. Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 2004; 65(6): 1991-2002Schaeffner ES, Kurth T, Curhan GC et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14(8): 2084-2091Schaeffner ES, Kurth T, Curhan GC et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14(8): 2084-2091Tonelli M, Moyй L, Sacks FM et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003 14(6): 1605-1613Tonelli M, Moyй L, Sacks FM et al. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003 14(6): 1605-1613Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 2006; 21(8): 2133-2143Jones C, Roderick P, Harris S, Rogerson M. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 2006; 21(8): 2133-2143
The authors declare that there are no conflicts of interest present.